JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC CO., LTD.

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

JSP

THA520010002

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 18:00:00 2024-06-06 EDT			5-day change	1st Jan Change
2.42 ^THB	+0.83%		+2.54%	+5.22%

05-14	JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

JSP Pharmaceutical Manufacturing Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022

April 14, 2022

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was THB 83.4 million. Revenue was THB 85.47 million. Net loss was THB 11.58 million. Basic loss per share from continuing operations was THB 0.03.

Latest news about JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Establishes a New Subsidiary and Investing in A Subsidiary	23-08-24	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. completed the acquisition of 52.8% stake in Grace Water Med Co., Ltd from NCL International Logistics Public Company Limited.	23-05-22	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. agreed to acquire 52.8% stake in Grace Water Med Co., Ltd from NCL International Logistics Public Company Limited for THB 43.9 million.	23-05-14	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Proposes to Omit the Annual Dividend Payment for the Year 2022	23-02-28	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Jsp Pharmaceutical Manufacturing Public Co., Ltd. Approves the Establishment of the Company's Subsidiary	23-02-02	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. agreed to acquire 65% stake in CDIP Public Company Limited from group of sellers for THB 250 million.	23-02-01	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
187,687,500 Ordinary Shares of JSP Pharmaceutical Manufacturing Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2022.	22-11-01	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
JSP Pharmaceutical Manufacturing Public Co., Ltd. Announces Establishment of New Subsidiary	22-06-28	CI
62,562,500 Ordinary Shares of JSP Pharmaceutical Manufacturing Public Company Limited are subject to a Lock-Up Agreement Ending on 2-MAY-2022.	22-05-01	CI
JSP Pharmaceutical Manufacturing Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-14	CI
JSP Pharmaceutical Manufacturing Public Company Limited Approves Dividend for the Year Ended 31 December 2021, Payable on 29 April 2022	22-04-05	CI
JSP Pharmaceutical Manufacturing Public Company Limited Proposes Dividend from January 1, 2021 to December 31, 2021, Payable on 29 April 2022	22-02-28	CI
JSP Pharmaceutical Manufacturing Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
JSP Pharmaceutical Manufacturing Public Company Limited Receives of Narcotics Substance Type 5 License (Hemp Only)	22-02-23	CI

Chart JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

Duration

Period

Chart JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

More charts

Company Profile

JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customerâs brand name (OEM), as well as under the Companyâs brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customersâ trademark (OEM) and the seller of the products under the Companyâs trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Companyâs subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.

Sector

Pharmaceuticals

Calendar

2024-10-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC CO., LTD.	+5.22%	31.25M
ELI LILLY AND COMPANY	+45.82%	754B
NOVO NORDISK A/S	+40.95%	630B
JOHNSON & JOHNSON	-6.16%	352B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	298B
ASTRAZENECA PLC	+18.45%	250B
NOVARTIS AG	+11.88%	217B
ROCHE HOLDING AG	-0.78%	216B
AMGEN INC.	+5.90%	164B